trans-8-(4-Aminocyclohexylamino)-N-(4-(dimethylamino)-benzyl)-5-bromo-1,6-naphthyridine-7-carboxamide

ID: ALA2180564

PubChem CID: 45376976

Max Phase: Preclinical

Molecular Formula: C24H29BrN6O

Molecular Weight: 497.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)cc1

Standard InChI:  InChI=1S/C24H29BrN6O/c1-31(2)18-11-5-15(6-12-18)14-28-24(32)22-21(29-17-9-7-16(26)8-10-17)20-19(23(25)30-22)4-3-13-27-20/h3-6,11-13,16-17,29H,7-10,14,26H2,1-2H3,(H,28,32)/t16-,17-

Standard InChI Key:  KEEFQVUNBAEVIL-QAQDUYKDSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    2.6483  -10.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6471  -10.9395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3593  -11.3526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0731  -10.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0702  -10.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3575   -9.7069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7856  -11.3506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4967  -10.9368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2092  -11.3484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9204  -10.9345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2105  -12.1697    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6275  -11.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6199   -9.7048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9162  -10.1162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3373  -10.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3345  -10.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0418  -11.3435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7525  -10.9338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7514  -10.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0435   -9.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6157   -8.8835    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    7.6300  -12.1688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3389  -12.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3373  -13.3893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0422  -13.7957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7511  -13.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7506  -12.5703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0412  -12.1594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4585  -13.7975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410   -9.7065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9418   -8.8893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2328  -10.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  2  0
 12 16  1  0
 15 13  1  0
 13 14  2  0
 14 10  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 15  2  0
 13 21  1  0
 12 22  1  0
 23 22  1  1
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 26 29  1  6
  1 30  1  0
 30 31  1  0
 30 32  1  0
M  END

Associated Targets(Human)

HEY (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 497.44Molecular Weight (Monoisotopic): 496.1586AlogP: 4.07#Rotatable Bonds: 6
Polar Surface Area: 96.17Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.46CX Basic pKa: 10.45CX LogP: 3.61CX LogD: 0.87
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.21

References

1. Zeng LF, Wang Y, Kazemi R, Xu S, Xu ZL, Sanchez TW, Yang LM, Debnath B, Odde S, Xie H, Zheng YT, Ding J, Neamati N, Long YQ..  (2012)  Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.,  55  (22): [PMID:23098137] [10.1021/jm300667v]

Source